Join the club for FREE to access the whole archive and other member benefits.

SenoStem project to investigate whether prior delivery of senolytic improves stem cell treatment

Both are leading first generation longevity treatments - even better if they strengthen each other

07-Feb-2022

Key points from article :

The accumulation of damaged/senescent cells in the body with time is a hall mark of aging.

Prior removal of senescent cells will likely enhance the effectiveness of stem cell transplantation therapies.

SenoStem project will test whether this creates a more favorable niche for stem cells to engraft.

Overall aim is to determine whether these two different lifespan-extending interventions can act synergistically.

First phase will be to carryout in vitro and in vivo studies in order to identify the most effective and safe senolytic.

Second phase will assess the effectiveness of lead senolytic followed by transplantation of stem cells.

Expectation is that the combination therapy will be more effective than either the senolytic or stem cell treatment alone.

Mentioned in this article:

Click on resource name for more details.

SENS Research Foundation

Non-profit organization focused on transforming the way the world researches and treats age-related diseases

Topics mentioned on this page:
Senescent Cells, Stem Cells